Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Intermittent Fasting in Improving High Density Lipoprotein Cholesterol

NCT03805776 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.

NCT NCT03805776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03805776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Intermittent Fasting in Improving High Density Lipoprotein Cholesterol
Lead sponsor
Aga Khan University
Phase
Not applicable
Overall status
Unknown status
Start date
February 20, 2019
Completion date
September 15, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, cardiac function, dyslipidemias, hdl cholesterol, low serum, hepatic enzymes and function abnormalities, intermittent fasting, kidney diseases